Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • How big is the problem?
    • How we drive change
    • Our story
  • Featured insights
    • The latest at the Foundation
    • The latest at the Foundation
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • Become a catalyst
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
  • Achievements so far
    • The Foundation's impact
    • The Foundation's impact
  • News
  • Our team
  • Our impact
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us
Photo of: Klara Tisocki
Member of the 2022 Expert Review Committee for the Access to Medicine Index

Klara Tisocki

Klara Tisocki is trained as a clinical pharmacologist and has over 25 years of working experience in improving pharmaceutical systems in low- and middle-income countries. She has worked across Africa and Asia on pharmaceutical policy development, medicines and medical product regulation, procurement and supply management, access to medicines and pricing issues. She has served as the Regional Medicines adviser both in the WHO Western Pacific and WHO South East Asia Regional Offices since 2012.

Klara joined WHO headquarters in 2020 as a Team Lead for Medicines and Health Products Pricing and Affordability in the Department of Health Products Policy. She is responsible for the global level coordination of WHO's technical support to countries related to policy development on medicines and health product pricing; access issues; and monitoring the availability, affordability and prices of medicines.

The Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Copyright 2004 - 2022 Access to Medicine Foundation - All Rights Reserved